Cancer Genetics, Inc.


Updates from The Motley Fool

Latest updates on Cancer Genetics from Fool.com.

There is no available coverage of Cancer Genetics at this time.



Stock Performance

View Interactive CGIX Charts
Sponsored by

Key Data Points

Primary metrics and data points about Cancer Genetics.
Current Price: $3.95
Prev Close: $4.00
Open: $3.90
Bid: $3.85
Ask: $4.80
Day's Range: $3.90 - $4.00
52wk Range: $1.10 - $5.30
Volume: 234,464
Avg Vol 331,402
Market Cap: $78M
P/E (ttm): -3.53
EPS (ttm): ($1.12)
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about Cancer Genetics.
CAPS Rating 1 out of 5
 
28 Outperform
5 Underperform
CAPS All Stars
 
5 Outperform
4 Underperform

How do you think Cancer Genetics will perform against the market?



You pick for Cancer Genetics is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Panna Sharma, CEO

31% Approve

Based on 20 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for Cancer Genetics.

Cancer Genetics, Inc.

  • Exchange: NASDAQ